As part of a prospective study of the neurologic and neuropsychological complications of
coronary artery bypass graft surgery, 312 patients were compared with a control group of 50 …

The recent discovery that defects in the gene encoding copper‐zinc superoxide dismutase (SOD1)
are associated with some cases of familial motor neuron disease has heightened …

Background Relapsed acute lymphoblastic leukemia (ALL) is difficult to treat despite the
availability of aggressive therapies. Chimeric antigen receptor–modified T cells targeting CD19 …

Fasting plasma and/or CSF amino acid levels have been measured in a group of 37 patients
with motor neurone disease (MND) and in 35 neurological control patients undergoing …

Spinal muscular atrophy is one of the most common genetic causes of death in childhood,
and there is currently no effective treatment. The disease is caused by mutations in the …

Patients with multiply relapsed or refractory chronic lymphocytic leukemia (CLL) have a
poor prognosis. Chimeric antigen receptor (CAR)–modified T cells targeting CD19 have the …

Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease, is characterized
by the degeneration of both upper and lower motor neurons, which leads to muscle …

Objective Amyotrophic lateral sclerosis (ALS) is a common, fatal motor neuron disorder with
no effective treatment. Approximately 10% of cases are familial ALS (FALS), and the most …

Background The intrathecally administered antisense oligonucleotide tofersen reduces
synthesis of the superoxide dismutase 1 (SOD1) protein and is being studied in patients with …

Background Few patients with amyotrophic lateral sclerosis currently receive non-invasive
ventilation (NIV), reflecting clinical uncertainty about the role of this intervention. We aimed to …